gbm

Showing 1 - 25 of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

Recruiting
  • Glioblastoma
  • GBM
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023

GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)

Recruiting
  • GBM
  • Postoperative radiotherapy for SVZ
  • Nanjing, Jiangsu, China
    Lining Guo
Oct 14, 2023

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

GBM Trial (Lenvatinib, Pembrolizumab, Tumor Treating Fields (TTFields))

Not yet recruiting
  • GBM
  • (no location specified)
Aug 2, 2023

Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

Recruiting
  • Glioma, Malignant
  • +6 more
  • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 13, 2023

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • SonoCloud-9 (SC9)
  • +3 more
  • Chicago, Illinois
  • +7 more
Jun 5, 2023

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

GBM, Glioma Glioblastoma Multiforme, Tumor, Brain Trial (Whole Brain Spectroscopy Imaging Array Mapping Layout)

Recruiting
  • GBM
  • +2 more
  • Whole Brain Spectroscopy Imaging Array Mapping Layout
  • Philadelphia, Pennsylvania
  • +1 more
Jan 19, 2023

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

Completed
  • GBM
  • +3 more
  • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
  • Durham, North Carolina
    Duke University Medical Center
Jun 28, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

Completed
  • MGMT-unmethylated Glioblastoma (GBM)
  • GBM
  • New York, New York
    New York University School of Medicine
Jun 30, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

Recruiting
  • Glioblastoma
  • +6 more
  • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
  • Temozolomide and Radiation Alone
  • New York, New York
    Lenox Hill Brain Tumor Center
May 5, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

GBM Trial in Taichung, Taoyuan (autologous dendritic cells)

Recruiting
  • GBM
  • autologous dendritic cells
  • Taichung, Non-US, Taiwan
  • +2 more
Mar 21, 2022

Glioma, Glioblastoma, GBM Trial in Chandler, Phoenix, Scottsdale (Infigratinib)

Recruiting
  • Glioma
  • +2 more
  • Chandler, Arizona
  • +2 more
Mar 10, 2022

GBM, Glioblastoma, Brain Tumor Trial in Dallas (Abemaciclib, Bevacizumab)

Active, not recruiting
  • GBM
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 23, 2022